Cannabis clinic support for first episode psychosis
Part of Mental health clinical trials.
This trial tests a special clinic that helps people with a first episode of psychosis cut down or stop using cannabis. The clinic provides talking support and practical help, and the goal is to improve your mental health and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a first episode of psychosis and are currently receiving care from a community mental health team in South London (SLaM).
- You use cannabis and score 9 or higher on a cannabis use screening test, meaning you likely have a cannabis use problem.
- You are between 18 and 65 years old.
- You are able to understand the trial and give informed consent.
- You are not at high risk of suicide and you don't use other illegal drugs (like cocaine or heroin) more than twice a week.
- You are not currently taking part in any other treatment trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two smartphone apps designed to help young adults with psychosis who use cannabis. One app helps reduce use, and the other helps people who want to quit or cut down. The goal is to see if these apps improve cannabis habits and mental health.
This trial tests a short, one-time program designed to help people ages 18-25 who use cannabis frequently (at least 20 days per month) reduce their use. It may be a good fit if you're not already in treatment and are thinking about making a change.
This study tests if psilocybin (a substance that can change how you think and feel) can help people reduce or stop using cannabis. You will receive support and be monitored closely throughout the trial.
This study looks at how to improve early psychosis care using data-driven planning and support for people who are newly developing symptoms. It may help by sharing better ways to coordinate treatment among patients, families, and the clinic/community teams.
This study tests a computer-based cognitive training program to help people with early psychosis reduce their alcohol and cannabis use. The program is designed to improve thinking skills and may make it easier to cut back on substance use.
This study tests if adding a CBD medication to your current antipsychotic can improve symptoms in people with schizophrenia or related disorders who started treatment recently but aren't fully better yet.
Hear when a new Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.